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Summary: A method is described for the determination of VLDL apolipoprotein B by radial immunodiffusion
(RID) in serum supernatants following precipitation of LDL with polyvinylsulphate. The rneasurement of
VLDL apolipoprotein B is based on the incubation of the polyvinylsulphate supernatant with triglyceride
lipase (330 kU/1 end concentration) for 12 — 24 hours at 37 °C. A good measure of agreement was found for
the corresponding VLDL apolipoprotein B values measured by RID in%the polyvinylsulphate supernatants
(y) and VLDL apolipoprotein B values calculated äs tetramethylurea-insohible protein in the d < 1.006 kg/l
serum fraction (x) (r = 0.88, y = 0.96x + 0.004, n = 54). Within the tested ränge of 1.2 mmol/1 to 6.7
mmol/1 triglycerides, the concentration of apolipoprotein B measured in the polyvinylsulphate supernatant
showed a linear relationship. Correlation analysis of VLDL apolipoprotein B values and serum triglycerides
\ and VLDL cholestefol, respectively, showed a good correlation (r = 0.77 and r = 0.75, respectively, n =
( 54). In the determination of VLDL apolipoprotein B measured in polyvinylsulphate supernatant, a Variation
coefficient of 4.3% (x = 10.1 mmol/1, n = 20) was found in relation to the precision in the series, and a
[ Variation coefficient of 11.4% (x = 5.3 mmol/1, n = 15) in relation to day to day precision.
VLDL Apolipoprotein B Bestimmung im Blutserum nach Präzipitation von LDL mit Polyvinylsulfat
Zusammenfassung: Es wird eine Methode zur Bestimmung von VLDL Apolipoprotein B mittels radialer
Immundiffusion (RID) im Fällungsüberstand nach Vorheriger Präzipitation der LDL mit Polyvinylsulfat
i beschrieben. Die Richtigkeit der Messung von VLDL Apolipoprotein B gründet sich auf die Inkubation der
j Poly vinylsülfat-Fällungsüberstände mit Triglyceridlipase (330 kU/1 Endkonzentration) für 12—24 Stunden bei
| 37 °C. Es wurde eine gute Übereinstimmung der VLDL Apolipoprotein B-Wertepaare gefunden, die mittels
| RID im Polyvinylsulfat-Überstand (y) gemessen und als Tetramethylharnstoff unlösliches Protein in der
j d < 1,006 kg/l Serumfraktion (x) ermittelt wurden (r = 0,88, y = 0,96x + 0,004, n = 54). Innerhalb des
untersuchten Bereichs von 1,2 miiiol/1 bis 6,7 mmol/1 Triglyceriden waren die VLDL Apolipoprotein B-Werte
im Fällungsüberstand linear. Die Kprrelationsanalyse der im Polyvinylsialfat-Fällungsüberstand gemessenen
VLDL Apolipoprotein B-Werte und der Triglycerid- bzw. der VLDL Cholesterinwerte im Serum ergab eine
gute Korrelation der jeweiligen Wertepaare (r = 0,77, bzw. r = 0,75; n = 54). Der Variationskoeffizient der
VLDL Apolipoprotein B-Bestimmung' nach Polyvinylsulfat-Fällung hinsichtlich der Präzision in der Serie
i betrug 4,3% (x = 10,1 mmöl/1, n = 20) und hinsichtlich der Präzision von Tag zu Tag 11,4% (x = 5,3
l mmol/1, n = 15).
Introduction (LDL). Normally, more than 90% of total apo-
Apolipoprotein B represents the functional entity of lipoprotein B is transported in LDL, whereas
several lipoproteins, especially of very low density apprpximately 4 — 5% of total apolipoprotein B is
lipoproteins (VLDL) and low density lipoproteins found in VLDL (l). LDL apolipoprotein B represents
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the marker for the recognition of LDL by peripheral
and hepatic receptors (2). It is well known that in-
creased concentrations of apolipoprotein B-con-
taining lipoproteins are associated with premature
atherosclerosis (3, 4). Thus, quantification of apo-
lipoprotein B is possibly relevant for clinical and
epidemiological purposes. The determination of apo-
lipoprotein B in LDL or VLDL usually implies a time
consuming Separation of lipoproteins. Furthermore,
the accurate measurement of apolipoproteins has
been hampered by technical problems (5).
According to studies of Franceschini et al. (6), in-
creased concentrations of apolipoprotein B in VLDL
are associated with peripheral vascular disease.
Therefore, the determination of VLDL apo-
lipoprotein B may be of special clinical and
epidemiological significance. Recently a commercial
test has been developed for the analysis of LDL
cholesterol following selective precipitation of LDL
with polyvinylsulphate (7). Using this procedure we
have developed a method for the determination of




As test material we used fresh serum from the test series "Pro-
spective epidemiological study in Company employees in
Westfalia" (8).
Precipitation of LDL with polyvinylsulphate
Precipitation of LDL with polyvinylsulphate was performed s
previously described (7) using the Boehringer Mannheim test,
catalogue no. 726290 (Boehringer Mannheim, FRG). For the
LDL precipitation 200 μΐ serum were mixed in an incubation
tube (Sarstedt no. 52690) with 100 μΐ precipitation reagent, left
at room temperature for 15 minutes and centrifuged in an
Eppendorf centrifuge 3200 for 2 χ 2 minutes.
Determination of VLDL cholesterol
In the supernatant obtained by polyvinylsulphate precipitation
cholesterol was determined enzymatically using the cholesterol
oxidase/4-aminophenazone phenol method (Boehringer
Mannheim monotest cholesterol, cat. no. 237574). HDL cho-
lesterol was determined by measuring cholesterol in the
supernatant (Boehringer Mannheim monotest cholesterol high
Performance, cat. no. 737574) following precipitation of apo-
lipoprotein B-containing lipoproteins in serum using
phosphotungstate/MgC!2 (9). VLDL cholesterol was calculated
from the difference between cholesterol in the polyvinylsulphate
supernatant and HDL cholesterol.
Determination of apolipoprotein B by radial immunodiffusion
(RIO)
Supernatant (100 μΐ) obtained by polyvinylsulphate pre-
cipitation of serum was mixed with 50 μΐ triglyceride lipase (l
MU/1, Calbiochem. Behring Corp., La Jolla Ca, 92037, order
no. 437611). The enzyme was solubilised in saline containing
0.02 mol/1 Na-phosphate buffer pH 8.0, according to Kostner
(personal cornmunication). The mixture was incubated at 37 °C
for 12—24h and centrifuged at approximately 1000g. RID
was performed according to Mancini et al. (10). Anti-apo-B (40
μΐ) (Immunoscientific Anti Apo B, Immuno AG, Vienna, order
no. 48340005) was mixed with 20 ml of 10 g/i solution of agarose
in Tris-barbital-lactate buffer pH 8.6 (0.045 mol/1 Tris, 0.015
mol/1 barbituric acid, 1.9 mmol/1 Na^ zide, 0.21 mmol/1 Ca-
lactate). The volurhe of the lipase-treated sample was 10 μΐ. As
Standard we used RID Reference Standard Apoproteins human
(Immuno Comp. D-6900 Heidelberg, order no. 4910005). Stan-
dard Solutions were diluted with 0.15 mol/1 NaCl 1:2, 1:4,1:8,
1:16, 1:32, 1:64. The .Standard was not tre ted with lipase.
Incubation time was 4 days at roorn temperature. The diameter
of the precipitation rings obtained were measured following
staining with Servablue R (Serva, 6900 Heidelberg, FRG).
Preparative Isolation of VLDL by ultracentrifugation
Preparative Isolation of VLDL by ultracentrifugation was per-
formed s previously described (11).
Determination of tetramethylurea-insoluble protein in VLDL
(d < i.006 kg/l serum fraction)
Determination of the tetramethylurea-insoluble protein in
VLDL (d < 1.006 kg/l serum fraction) was performed s de-
scribed by Kane et al (12).
Determination of triglycerides
Triglycerides were determined fully enzymatically using the
enzymatic triglyceride assay after enzymatic hydrolysis
(Boehringer Mannheim test combination triglyceride
vollenzymatisch UV-Test, cat. no. 240052).
Results
Influence of lipase on apolipoprotein B determination
in the polyvinylsulphate supernatant
The incubation of the supernatant following pre-
cipitation of sera with polyvinylsulphate using
triglyceride lipase caused an increase in the diameter
of the precipitation rings. As shown in figure l, the
calculated apolipoprotein B values in the supernatant
rose on average by 78% in comparison to untreated
samples.
Comparison of apolipoprotein B in polyvinylsulphate
supernatant and tetramethylurea-insoluble protein in
the d < i.006 kg//,serum fraction
Apolipoprotein B values were measured in the poly-
vinylsulphate supernatant of serum, and they were
calculated s the VLDL tetramethylurea-insoluble
protein in normo- and hypertriglycerid emic sera.
Both methods gave similar Values (r = 0.76, y =
l.lx — 0.012, n = 18). As secondary Standard we
used the polyvinylsulphate supernatant of a pool
serum. The apolipoprotein B concentration of this
secondary Standard was determined s the VLDL» i
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Fig. 1. Influence of lipase treatment (330 kU/1 end con-
centration) of the polyvinylsulphate supernatant on the








0 0.1 0.2 0.3 ΟΛ 0.5 0.6
Tetramethyturea insoluble protein in d<1.006 kg/l
yltrazentrifugotion fradion [g/l]
Fig. 2. Regression analysis of VLDL apolipoprotein B values
calculated s the VLDL tetramethylurea insoluble pro-
tein (x) versus apolipoprotein values measured in the
lipase treated polyvinylsulphate supernatant of sera (y);
r = 0.88, y = 0.96x + 0.004, n = 54.
tetramethylurea-insoluble protein. Using the RID
Reference Standard (Immuho Comp.) for standard-
isation, similar results were obtained (r = 0.88, y =
0.96x + 0.004, n = 54) (fig. 2), The applicability of
the RID Reference Standard (Irnmuno Comp.) was
tested by recalculation of the apolipoprotein B value
using the secondary Standard (see above) (tab. 1).
Regression analysis of the apolipoprotein B values in
the polyvinylsulphate supernatant and apo-
lipoprotein B values in the d < 1.006 kg/l serum
fraction treated with triglyceride lipase, both meas-
ured by RID, showed different results. On the average
apolipoprotein B values in the polyvinylsulphate
supernatant were 18.5% higher than apo-
lipoprotein B values in the d < 1.006 kg/l serum
fraction (r = 0.48, y = 1.5x - 0.04, n = 23).
However, this difference was not observed when
albumin was added to the d < 1.006 kg/l fraction
(40 g/l end concentration) before incubation with
triglyceride lipase.
Tab. 1. Recalculation of the apolipoprotein B cpncentration
(g/l) in RID Reference Standard (Immuno Comp.). A
polyvinylsulphate supernatant of a pool serum was used
s Standard, in which the apolipoprotein B con-





















Comparison of VLDL apolipoprotein B with
triglycerides and VLDL cholesterol
There was a good correlation of the VLDL apo-
lipoprotein B values with triglycerides and VLDL
cholesterol, irrespective of whether the apo-
lipoprotein B values were calculated s VLDL
tetramethylurea-insoluble protein or measured in the
polyvinylsulphate supernatant (tab. 2).
Tab. 2. Coefficients of the correlation analysis of VLDL
apolipoprotein B versus VLDL cholesterol and
triglycerides, respectively.
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Linearity of apolipoprotein B values
Linearity of apolipoprotein B values using poly-
vinylsulphate precipitation was studied using dif-
ferent mixtures of two sera with considerably dif-
ferent triglyceride values (fig. 3). It was found that
the apolipoprotein B value measured in the poly-
vinylsulphate supernatant was proportional to the
ratio of components below a triglyceride con-
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Fig. 3. Apolipoprotein B concentration in lipase treated poly-
vinylsulphate supernatant äs a function of the volume
ratio when two sera with high (serum I, 15.0 mmol/1)
and low (1.22 mmol/1) triglyceride concentrations were
mixed.
Precision of the apolipoprotein B determination in the
polyvinylsulphate supernatant
With regard to the precision in the series a Variation
coefficient of 4.3% (n = 20) was found. Day to day
precision (l l .4% (n = 15)) was tested with samples of
frozen pool serum which had been stored at -30 °C.
Discussion
In the present study apolipoprotein B was determined
in the supernatant obtained after precipitation of
VLDL with polyvinylsulphate. In a previous study
we showed that polyvinylsulphate precipitation was
selective for LDL and Lp(a) with only negligible
coprecipitation of VLDL or HDL (7). Regression
analysis of the VLDL cholesterol values calculated
in the polyvinylsulphate supernatant and calculated
by ultracentrifugation showed a good correspondence
of results (7). It may be assumed that VLDL apo-
lipoprotein B behaves exactly like cholesterol in the
polyvinylsulphate precipitation procedure. As our re-
sults show, VLDL apolipoprotein B measured in the
polyvinylsulphate supernatant agreed on average
excellently with tetramethylureä-insoluble proteins
measured in the d < 1.006 kg/l serum fraction. The
determination of the VLDL tetfamethylurea4n-
soluble protein is geherally considered äs the ref-
erence method for the determination of VLDL apo^
lipoprotein B (12,13). However, the determination of
the VLDL tetramethylureä-insoluble protein is an
elaborate and time consuming method and is not
sufficiently precise becaüse apolipoprotein B is cal-
culated äs the difference between total protein and
tetramethylurea-soluble protein. Possibly the large
scatter obtained in the regression analysis of our
results may be explained by the imprecision of the
reference method used. In contrast to the reference
method our results showed an improved precision
using the direct measurement of apolipoprotein B in
the polyvinylsulphate supernatant.
Compared with total apolipoprotein B in plasma, the
apolipoprotein B concentration in VLDL is low
(4-5%). Therefore, for the determination of VLDL
apolipoprotein B a sensitive method is necessary. In
our study the sensitivity of the RID was enhanced
by the reduction of antibody concentration to 0.2%.
After staining with Coomassie blue the ring diameters
could be clearly visualised. The lower limit of de-
tection was 23 mg/1 VLDL apolipoprotein B.
<..
According to our results, only lipase-treated samples
yielded correct VLDL apolipoprotein B Values in the
polyvinylsulphate supernatant. Compared with
untreated samples, lipase treatment resulted in a sig-
nificant increase of the ring diameters, especially in
samples obtained from hypertriglyceridäemic indivi-
duals. The effect of lipase treatment on the ring
diameter may be based on a change of im*
munoreactivity. Similar observations were previously
made by Schonfeld et al. (14). These authors found
an increase in the apparent apolipoprotein B content
of VLDL treated by lipoprotein lipase only in those
assays that contained anti-LDL antisera but not in
those assays that contained anti-VLDL antisera. Ob-
viously, the anti-LDL antibodies also used in our
experiments do not recognise all antigenic sites of
the apolipoprotein B component in VLDL. However,
lipase treatment äs well äs treatment with lipoprotem
lipase may change the immunoreactivity, either by
removing lipids and apolipoproteins during lipolysis,
so that masked areas of apolipoprotein B become
uncovered, or by converting latger VLDL particles
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into smaller ones so that apolipoprotein B on the
surface of the particles is altered to adjust to the new
surface geometry and composition of the particles. It
must be considered that triglyceride lipase possibly
produces side effects; for example, it may cleave leci-
thin into lysolecithin (phospholipase activity) which
is known to be an effective detergent.
In contrast to the significant enhancement of the
immunoreactivity using the polyvinylsulphate
supernatant, the enhancement of the im-
munoreactivity in the d < l .006 kg/l serum fraction
following lipase treatment is very small. Since the
addition of albumin to the VLDL fraction, which is
obviously poor in albumin, resulted in an increase in
immunoreactivity it can be concluded that free fatty
acids generated by the lipase resulted in an Inhibition
of the immunoreactivity. On the other band, the
polyvinylsulphate supernatant contains all the plasma
albumin which binds the free fatty acids generated
by the lipase.
In spite of the heterogeneous composition of VLDL
in hypertriglyceridaemic sera, the linearity of our
method extended to a triglyceride concentration of
approximately 6.7 mmol/1. Also, in hyper-
triglyceridaemic sera, VLDL apolipoprotein B values
in polyvinylsulphate supernatant were in good agree-
ment with the VLDL apolipoprotein B values meas-
ured by the reference method.
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